The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Lafrance Norman D. since year 2005.
The trader's CIK number is 1397768.
At the time of this reporting, Lafrance Norman D. is the Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc. .
(stock ticker symbol MIPI).
See this page for all insider trading activities at Molecular Insight Pharmaceuticals, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2009-05-28 | MIPI | Molecular Insight Pharmaceuticals, Inc. | Sale | 6,093 | 3.76 | 22,909 |
| 2007-11-30 | MIPI | Molecular Insight Pharmaceuticals, Inc. | Buy | 2,000 | 8.76 | 17,530 |
| 2007-11-29 | MIPI | Molecular Insight Pharmaceuticals, Inc. | Buy | 2,000 | 8.00 | 16,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lafrance Norman D. (Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.